Comparison of Etamsylate Versus Placebo to Prevent Bleeding in HSCT

Summary

This study employs a prospective, randomized, double-blind, placebo-controlled design. It aims to compare the efficacy of etamsylate versus placebo in preventing bleeding complications in patients with thrombocytopenia following hematopoietic stem cell transplantation.

Timeline

Start

2025-12-16

Primary completion

2027-10-31

Completion

2027-10-31

Drugs

Indications